Table of Contents Executive Summary 1 Industry Overview of End-Stage Kidney Disease Treatment 1.1 Definition of End-Stage Kidney Disease Treatment 1.2 End-Stage Kidney Disease Treatment Segment by Type 1.2.1 Global End-Stage Kidney Disease Treatment Production Growth Rate Comparison by Types (2014-2025) 1.2.2 MK-3866 1.2.3 Pacritinib 1.2.4 Sanguinate 1.2.5 Tesidolumab 1.2.6 Others 1.3 End-Stage Kidney Disease Treatment Segment by Applications 1.3.1 Global End-Stage Kidney Disease Treatment Consumption Comparison by Applications (2014-2025) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Global End-Stage Kidney Disease Treatment Overall Market 1.4.1 Global End-Stage Kidney Disease Treatment Revenue (2014-2025) 1.4.2 Global End-Stage Kidney Disease Treatment Production (2014-2025) 1.4.3 North America End-Stage Kidney Disease Treatment Status and Prospect (2014-2025) 1.4.4 Europe End-Stage Kidney Disease Treatment Status and Prospect (2014-2025) 1.4.5 China End-Stage Kidney Disease Treatment Status and Prospect (2014-2025) 1.4.6 Japan End-Stage Kidney Disease Treatment Status and Prospect (2014-2025) 1.4.7 Southeast Asia End-Stage Kidney Disease Treatment Status and Prospect (2014-2025) 1.4.8 India End-Stage Kidney Disease Treatment Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of End-Stage Kidney Disease Treatment 2.3 Manufacturing Process Analysis of End-Stage Kidney Disease Treatment 2.4 Industry Chain Structure of End-Stage Kidney Disease Treatment 3 Development and Manufacturing Plants Analysis of End-Stage Kidney Disease Treatment 3.1 Capacity and Commercial Production Date 3.2 Global End-Stage Kidney Disease Treatment Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of End-Stage Kidney Disease Treatment 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 End-Stage Kidney Disease Treatment Production and Capacity Analysis 4.2 End-Stage Kidney Disease Treatment Revenue Analysis 4.3 End-Stage Kidney Disease Treatment Price Analysis 4.4 Market Concentration Degree 5 End-Stage Kidney Disease Treatment Regional Market Analysis 5.1 End-Stage Kidney Disease Treatment Production by Regions 5.1.1 Global End-Stage Kidney Disease Treatment Production by Regions 5.1.2 Global End-Stage Kidney Disease Treatment Revenue by Regions 5.2 End-Stage Kidney Disease Treatment Consumption by Regions 5.3 North America End-Stage Kidney Disease Treatment Market Analysis 5.3.1 North America End-Stage Kidney Disease Treatment Production 5.3.2 North America End-Stage Kidney Disease Treatment Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America End-Stage Kidney Disease Treatment Import and Export 5.4 Europe End-Stage Kidney Disease Treatment Market Analysis 5.4.1 Europe End-Stage Kidney Disease Treatment Production 5.4.2 Europe End-Stage Kidney Disease Treatment Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe End-Stage Kidney Disease Treatment Import and Export 5.5 China End-Stage Kidney Disease Treatment Market Analysis 5.5.1 China End-Stage Kidney Disease Treatment Production 5.5.2 China End-Stage Kidney Disease Treatment Revenue 5.5.3 Key Manufacturers in China 5.5.4 China End-Stage Kidney Disease Treatment Import and Export 5.6 Japan End-Stage Kidney Disease Treatment Market Analysis 5.6.1 Japan End-Stage Kidney Disease Treatment Production 5.6.2 Japan End-Stage Kidney Disease Treatment Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan End-Stage Kidney Disease Treatment Import and Export 5.7 Southeast Asia End-Stage Kidney Disease Treatment Market Analysis 5.7.1 Southeast Asia End-Stage Kidney Disease Treatment Production 5.7.2 Southeast Asia End-Stage Kidney Disease Treatment Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia End-Stage Kidney Disease Treatment Import and Export 5.8 India End-Stage Kidney Disease Treatment Market Analysis 5.8.1 India End-Stage Kidney Disease Treatment Production 5.8.2 India End-Stage Kidney Disease Treatment Revenue 5.8.3 Key Manufacturers in India 5.8.4 India End-Stage Kidney Disease Treatment Import and Export 6 End-Stage Kidney Disease Treatment Segment Market Analysis (by Type) 6.1 Global End-Stage Kidney Disease Treatment Production by Type 6.2 Global End-Stage Kidney Disease Treatment Revenue by Type 6.3 End-Stage Kidney Disease Treatment Price by Type 7 End-Stage Kidney Disease Treatment Segment Market Analysis (by Application) 7.1 Global End-Stage Kidney Disease Treatment Consumption by Application 7.2 Global End-Stage Kidney Disease Treatment Consumption Market Share by Application (2014-2019) 8 End-Stage Kidney Disease Treatment Major Manufacturers Analysis 8.1 BLR Bio LLC 8.1.1 BLR Bio LLC End-Stage Kidney Disease Treatment Production Sites and Area Served 8.1.2 BLR Bio LLC Product Introduction, Application and Specification 8.1.3 BLR Bio LLC End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 CTI BioPharma Corp 8.2.1 CTI BioPharma Corp End-Stage Kidney Disease Treatment Production Sites and Area Served 8.2.2 CTI BioPharma Corp Product Introduction, Application and Specification 8.2.3 CTI BioPharma Corp End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 F. Hoffmann-La Roche Ltd 8.3.1 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production Sites and Area Served 8.3.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification 8.3.3 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Novartis AG 8.4.1 Novartis AG End-Stage Kidney Disease Treatment Production Sites and Area Served 8.4.2 Novartis AG Product Introduction, Application and Specification 8.4.3 Novartis AG End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Prolong Pharmaceuticals LLC 8.5.1 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production Sites and Area Served 8.5.2 Prolong Pharmaceuticals LLC Product Introduction, Application and Specification 8.5.3 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 VESSL Therapeutics Ltd 8.6.1 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production Sites and Area Served 8.6.2 VESSL Therapeutics Ltd Product Introduction, Application and Specification 8.6.3 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 9 Development Trend of Analysis of End-Stage Kidney Disease Treatment Market 9.1 Global End-Stage Kidney Disease Treatment Market Trend Analysis 9.1.1 Global End-Stage Kidney Disease Treatment Market Size (Volume and Value) Forecast 2019-2025 9.2 End-Stage Kidney Disease Treatment Regional Market Trend 9.2.1 North America End-Stage Kidney Disease Treatment Forecast 2019-2025 9.2.2 Europe End-Stage Kidney Disease Treatment Forecast 2019-2025 9.2.3 China End-Stage Kidney Disease Treatment Forecast 2019-2025 9.2.4 Japan End-Stage Kidney Disease Treatment Forecast 2019-2025 9.2.5 Southeast Asia End-Stage Kidney Disease Treatment Forecast 2019-2025 9.2.6 India End-Stage Kidney Disease Treatment Forecast 2019-2025 9.3 End-Stage Kidney Disease Treatment Market Trend (Product Type) 9.4 End-Stage Kidney Disease Treatment Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 End-Stage Kidney Disease Treatment Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of End-Stage Kidney Disease Treatment Table Global End-Stage Kidney Disease Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global End-Stage Kidney Disease Treatment Production Market Share by Types in 2018 Figure MK-3866 Product Picture Figure Pacritinib Product Picture Figure Sanguinate Product Picture Figure Tesidolumab Product Picture Figure Others Product Picture Table Global End-Stage Kidney Disease Treatment Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global End-Stage Kidney Disease Treatment Consumption Market Share by Applications in 2018 Figure Clinic Figure Hospital Figure Others Figure Global End-Stage Kidney Disease Treatment Revenue (Million USD) (2014-2025) Figure Global End-Stage Kidney Disease Treatment Production (K Pcs) (2014-2025) Figure North America End-Stage Kidney Disease Treatment Market Size (Million USD) (2014-2025) Figure Europe End-Stage Kidney Disease Treatment Market Size (Million USD) (2014-2025) Figure China End-Stage Kidney Disease Treatment Market Size (Million USD) (2014-2025) Figure Japan End-Stage Kidney Disease Treatment Market Size (Million USD) (2014-2025) Figure Southeast Asia End-Stage Kidney Disease Treatment Market Size (Million USD) (2014-2025) Figure India End-Stage Kidney Disease Treatment Market Size (Million USD) (2014-2025) Table End-Stage Kidney Disease Treatment Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of End-Stage Kidney Disease Treatment in 2018 Figure Manufacturing Process Analysis of End-Stage Kidney Disease Treatment Figure Industry Chain Structure of End-Stage Kidney Disease Treatment Table Capacity and Commercial Production Date of Key Manufacturers Table Global End-Stage Kidney Disease Treatment Manufacturing Plants Distribution Table End-Stage Kidney Disease Treatment Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table End-Stage Kidney Disease Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019) Table End-Stage Kidney Disease Treatment Production (K Pcs) of Major Manufacturers (2014-2019) Table End-Stage Kidney Disease Treatment Production Market Share of Major Manufacturers (2014-2019) Figure End-Stage Kidney Disease Treatment Production Share by Manufacturers in 2018 Table End-Stage Kidney Disease Treatment Revenue (Million US$) of Major Manufacturers (2014-2019) Table End-Stage Kidney Disease Treatment Revenue Market Share of Major Manufacturers (2014-2019) Figure End-Stage Kidney Disease Treatment Revenue Share by Manufacturers in 2018 Table End-Stage Kidney Disease Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global End-Stage Kidney Disease Treatment Production by Regions 2014-2019 (K Pcs) Table Global End-Stage Kidney Disease Treatment Production Market Share by Regions 2014-2019 Figure Global End-Stage Kidney Disease Treatment Production Market Share by Regions in 2018 Table Global End-Stage Kidney Disease Treatment Revenue by Regions 2014-2019 (Million USD) Table Global End-Stage Kidney Disease Treatment Revenue Market Share by Regions 2014-2019 Figure Global End-Stage Kidney Disease Treatment Revenue Market Share by Regions in 2018 Table Global End-Stage Kidney Disease Treatment Consumption by Regions 2014-2019 (K Pcs) Table Global End-Stage Kidney Disease Treatment Consumption Market Share by Regions 2014-2019 Figure North America End-Stage Kidney Disease Treatment Production Growth Rate 2014-2019 (K Pcs) Figure North America End-Stage Kidney Disease Treatment Revenue Growth Rate 2014-2019 (Million USD) Table North America End-Stage Kidney Disease Treatment Production, Consumption Import and Export (K Pcs) Figure Europe End-Stage Kidney Disease Treatment Production Growth Rate 2014-2019 (K Pcs) Figure Europe End-Stage Kidney Disease Treatment Revenue Growth Rate 2014-2019 (Million USD) Table Europe End-Stage Kidney Disease Treatment Production, Consumption Import and Export (K Pcs) Figure China End-Stage Kidney Disease Treatment Production Growth Rate 2014-2019 (K Pcs) Figure China End-Stage Kidney Disease Treatment Revenue Growth Rate 2014-2019 (Million USD) Table China End-Stage Kidney Disease Treatment Production, Consumption Import and Export (K Pcs) Figure Japan End-Stage Kidney Disease Treatment Production Growth Rate 2014-2019 (K Pcs) Figure Japan End-Stage Kidney Disease Treatment Revenue Growth Rate 2014-2019 (Million USD) Table Japan End-Stage Kidney Disease Treatment Production, Consumption Import and Export (K Pcs) Figure Southeast Asia End-Stage Kidney Disease Treatment Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia End-Stage Kidney Disease Treatment Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia End-Stage Kidney Disease Treatment Production, Consumption Import and Export (K Pcs) Figure India End-Stage Kidney Disease Treatment Production Growth Rate 2014-2019 (K Pcs) Figure India End-Stage Kidney Disease Treatment Revenue Growth Rate 2014-2019 (Million USD) Table India End-Stage Kidney Disease Treatment Production, Consumption Import and Export (K Pcs) Figure Global Consumption End-Stage Kidney Disease Treatment Market Share by Application (2014-2019) Figure Global Value (Consumption) End-Stage Kidney Disease Treatment Market Share by Application (2014-2019) Table BLR Bio LLC End-Stage Kidney Disease Treatment Production Sites and Area Served Table BLR Bio LLC End-Stage Kidney Disease Treatment Product Introduction, Application and Specification Table BLR Bio LLC End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table BLR Bio LLC End-Stage Kidney Disease Treatment Production Growth Rate (2014-2019) Table BLR Bio LLC End-Stage Kidney Disease Treatment Production Market Share (2014-2019) Figure BLR Bio LLC End-Stage Kidney Disease Treatment Revenue Market Share (2014-2019) Table BLR Bio LLC End-Stage Kidney Disease Treatment Main Business and Markets Served Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Production Sites and Area Served Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Product Introduction, Application and Specification Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Production Growth Rate (2014-2019) Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Production Market Share (2014-2019) Figure CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue Market Share (2014-2019) Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Main Business and Markets Served Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production Sites and Area Served Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Product Introduction, Application and Specification Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production Growth Rate (2014-2019) Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production Market Share (2014-2019) Figure F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue Market Share (2014-2019) Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Main Business and Markets Served Table Novartis AG End-Stage Kidney Disease Treatment Production Sites and Area Served Table Novartis AG End-Stage Kidney Disease Treatment Product Introduction, Application and Specification Table Novartis AG End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Novartis AG End-Stage Kidney Disease Treatment Production Growth Rate (2014-2019) Table Novartis AG End-Stage Kidney Disease Treatment Production Market Share (2014-2019) Figure Novartis AG End-Stage Kidney Disease Treatment Revenue Market Share (2014-2019) Table Novartis AG End-Stage Kidney Disease Treatment Main Business and Markets Served Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production Sites and Area Served Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Product Introduction, Application and Specification Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production Growth Rate (2014-2019) Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production Market Share (2014-2019) Figure Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue Market Share (2014-2019) Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Main Business and Markets Served Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production Sites and Area Served Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Product Introduction, Application and Specification Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production Growth Rate (2014-2019) Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production Market Share (2014-2019) Figure VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Revenue Market Share (2014-2019) Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Main Business and Markets Served Figure Global End-Stage Kidney Disease Treatment Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global End-Stage Kidney Disease Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global End-Stage Kidney Disease Treatment Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America End-Stage Kidney Disease Treatment Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe End-Stage Kidney Disease Treatment Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China End-Stage Kidney Disease Treatment Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan End-Stage Kidney Disease Treatment Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia End-Stage Kidney Disease Treatment Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India End-Stage Kidney Disease Treatment Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India End-Stage Kidney Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of End-Stage Kidney Disease Treatment by Type (2019-2025) Table Global Consumption (K Pcs) of End-Stage Kidney Disease Treatment by Application (2019-2025) Table End-Stage Kidney Disease Treatment Distributors List Table End-Stage Kidney Disease Treatment Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

BLR Bio LLC CTI BioPharma Corp F. Hoffmann-La Roche Ltd Novartis AG Prolong Pharmaceuticals LLC VESSL Therapeutics Ltd